ArticleJournal of cancer immunology2025

Epigenetic Reprogramming with DNMT Inhibitors: A Multi-Mechanistic Approach to Enhance Immunotherapy in Glioblastoma.

Thomas J Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.